New publication: Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia

Recently the Economics of Genomics and Precision Medicine Unit conducted two DCEs as part of the BabyScreen+ program to elicit the Australian public’s preferences, values, and priorities for genomic newborn screening (gNBS) and its implementation.

The first DCE aimed to assess the value of gNBS (value DCE), while the second examined preferences regarding service delivery (implementation DCE), including when and how information about gNBS should be delivered and how results should be returned.

The findings of this work provide critical insights into the Australian public preferences and values for gNBS, and its translation and will enable cost-benefit evaluations to support the sustainable implementation of genomics into health systems.

Read the paper here: https://www.sciencedirect.com/science/article/pii/S0002929725001818